Novel treatment options for anaplastic thyroid cancer-Reference-Cited by-同舟云学术

Novel treatment options for anaplastic thyroid cancer

Published:2017-06-15 Issue:4 Volume:12 Page:279-288
ISSN:1744-6651
Container-title:Expert Review of Endocrinology & Metabolism
language:en
Short-container-title:Expert Review of Endocrinology & Metabolism

Author:

Fallahi Poupak¹,Ruffilli Ilaria¹,Elia Giusy¹,Ragusa Francesca¹,Ulisse Salvatore²,Baldini Enke²,Miccoli Mario¹,Materazzi Gabriele³,Antonelli Alessandro¹,Ferrari Silvia Martina¹

Affiliation:

1. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy

2. Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy

3. Department of Surgical, Medical, Molecular Pathology and Critical Area, University of Pisa, Pisa, Italy

Publisher

Informa UK Limited

Subject

Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.1080/17446651.2017.1340155

Reference123 articles.

1. A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the U.S., 1985-1995

2. Immediate Causes of Death in Thyroid Carcinoma: Clinicopathological Analysis of 161 Fatal Cases

3. 10.1007/b97251

4. New trends in the treatment of undifferentiated carcinomas of the thyroid

5. Anaplastic thyroid cancer: Rare, fatal, and neglected

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HRAS overexpression predicts response to Lenvatinib treatment in gastroenteropancreatic neuroendocrine tumors;Frontiers in Endocrinology;2023-01-20

2. Detection of BRAFV600E by digital PCR on fine-needle aspirate enables rapid initiation of dabrafenib and trametinib in unresectable anaplastic thyroid carcinoma;European Journal of Endocrinology;2022-09-01

3. In Vitro and In Vivo Effects of the Urokinase Plasminogen Activator Inhibitor WX-340 on Anaplastic Thyroid Cancer Cell Lines;International Journal of Molecular Sciences;2022-03-28

4. Papillary Thyroid Cancer Prognosis: An Evolving Field;Cancers;2021-11-07

5. Pyrvinium pamoate can overcome artemisinin’s resistance in anaplastic thyroid cancer;BMC Complementary Medicine and Therapies;2021-05-28